Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
3
75%
Ph not_applicable
1
25%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (75.0%)
N/A1 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

NCT00000904
completednot_applicable

The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys

NCT00031109
completedphase_1

A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

NCT00006509
completedphase_1

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

NCT00004579

Clinical Trials (4)

Showing 4 of 4 trials
NCT00000904Phase 1

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Completed
NCT00031109Not Applicable

The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys

Completed
NCT00006509Phase 1

A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Completed
NCT00004579Phase 1

A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Completed

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4